AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Liang Huang

Liang Huang

Tongji Medical College Huazhong University of Science and Technology - Wuhan / China
Medical and Health Sciences / Hematology
AD Scientific Index ID: 720066
华中科技大学同济医学院
person_outline Liang Huang's MOST POPULAR ARTICLES
1-) Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial Journal of Allergy and Clinical Immunology 146 (1), 137-146. e3, 2020
2-) Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients Cellular & molecular immunology 17 (9), 992-994, 2020
3-) Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies Blood, The Journal of the American Society of Hematology 135 (1), 17-27, 2020
4-) Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results Signal transduction and targeted therapy 8 (1), 5, 2023
5-) Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia Cell research 28 (2), 172-186, 2018